AER Electronic Filing Rule Sets Exemption Bar At Disaster Level
This article was originally published in The Tan Sheet
Executive Summary
FDA requires firms to submit post-market safety reports for drugs and biologics electronically beginning in June 2015. The agency says waivers will be allowed, but only will be temporary and rare, such as when disasters cut off electric power and Internet access.